Monetary Solutions’s AbbVie ABBV Stock Holding History

Monetary Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Hold	7,687	–	–	1.67%	15
2026 Q1	$1.67M	Hold	7,687	–	–	1.62%	15
2025 Q4	$1.76M	Buy	+7,687	New	+$1.75M	1.73%	14

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Monetary Solutions's ABBV Position: Q2 2026 in Review

Monetary Solutions held its AbbVie (ABBV) position steady in Q2 2026 at 7,687 shares worth $1.93M. The position accounts for 1.67% of the portfolio, ranked #15.

Monetary Solutions first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 3,584 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Monetary Solutions held 7,687 shares of AbbVie worth $1.93M as of Q2 2026.
Monetary Solutions left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.67% of Monetary Solutions's portfolio in Q2 2026, its #15 holding.
Monetary Solutions first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
3,584 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Monetary Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.